RESPIRATORY TRACT
RT-qPCR PANEL
The Respiratory Tract RT-qPCR Panel, offered by EndeXs Life Sciences, is meticulously designed to detect 24 respiratory tract infection (RTI)-related pathogens, including both viral and bacterial agents, in just 8 reactions per sample. This comprehensive panel leverages advanced RT-qPCR technology to ensure high sensitivity and specificity, providing laboratories with critical data to better understand the causes of respiratory diseases.
This Respiratory Pathogen Panel optimizes workflows, reduces assay time, and serves as a vital tool for laboratories studying respiratory health and pathogen dynamics.
Sample Type - Respiratory Research Samples
VTM Sample is mixed
with vNAT® Buffer
Reaction Setup
PCR Amplification
Automated Interpretation
10 Samples / 65 MINUTES
VIRUSES
SARS-CoV-2
Influenza A
Influenza B
Human Corona 229E-OC43-NL63-HKU1
Human Parainfluenza 1-2-3-4
Human Metapneumovirus
Adenovirus
Human Bocavirus
Enterovirus/Rhinovirus
Human Parechovirus
RSV A/B
BACTERIA
Streptococcus pneumoniae
Legionella pneumophila
Mycoplasma pneumoniae
Chlamydophila pneumoniae
Haemophilus Influenzae
Bordetella pertussis
SARS-CoV-2 RT-QPCR KIT
FDA-EUA
SARS-CoV-2 RT-qPCR FDA-EUA Kit offers an extraction-free workflow for detecting the SARS-CoV-2 virus, providing results within 60 minutes. The sample is made ready for RT-qPCR by treatment with vNAT® Buffer, a component that releases the nucleic acid, for 1 minute.
Sample Types - Nasopharyngeal Swabs, Oropharyngeal (Throat) Swabs, Combined Nasopharyngeal/ Oropharyngeal Swabs, Anterior Nasal Swabs, Mid-Turbinate Nasal Swabs, Nasal or Nasopharyngeal Aspirates, Nasal Washes, and Bronchoalveolar Lavage Samples.
94 samples / less than 60 MINUTES
VTM Sample is mixed with vNAT® Buffer
RT-qPCR Reaction
Automated Interpretation
TARGET GENES
FAM
HEX
Orf1ab
RNase P
Conserved SARS-CoV-2 genome region
Human RNAse P gene & mRNA (IC)
Sensitivity - 97.8%
Specificity - 100%
FDA-EUA products are medical devices or treatments authorized for emergency use by the U.S.
Food and Drug Administration during public health emergencies.
FDA-EUA
COVID-19/FLU/RSV
RT-qPCR KIT
RUO
COVID-19/Flu/RSV RT-qPCR Kit allows for the detection of four major respiratory pathogens in a single reaction.
Designed to accurately target Influenza A, Influenza B, SARS-CoV-2, and RSV, this kit provides valuable insights for scientists and researchers studying respiratory infections.
Sample Type - Respiratory Research Samples
Flu A-B/RSV RT-qPCR KIT
RUO
Researching prevalent respiratory infections is difficult due to the similar symptoms caused by different pathogens.
Flu A-B/RSV RT-qPCR Kit overcomes this challenge by detecting and differentiating between Influenza A, Influenza B, and RSV in just 45 minutes.
Sample Type - Respiratory Research Samples
For Research Use Only (RUO). Not for use in diagnostic procedures.
No claim or representation is intended to provide information about the diagnosis, prevention or treatment of the disease.